Skip to main content
. 2021 Sep 8;156(11):e214287. doi: 10.1001/jamasurg.2021.4287

Table 2. Perioperative Pain Characteristics, Pain Assessment, and Opioid Consumption.

Characteristic Control (n = 54) POINT (n = 48) P value
Perioperative pain characteristics and treatment
Perioperative pain treatment
Acetaminophen administered, No. (%) 44 (81.5) 42 (87.5) .43
Acetaminophen total dosage, median (IQR), mg 1000 (1000-1319) 1000 (1000-1650) .20
Total OMEs, median (IQR) 54.8 (30.0-88.3) 52.5 (37.9-77.8) .61
Inpatient postoperative pain scores, median (IQR)
4-h Postoperative pain score 0 (0-3) 2 (0-4) .11
Highest postoperative pain score 6 (4-7) 6 (3-7) .23
Last recorded pain score before discharge 0 (0-3) 1.5 (0-4) .17
Patient self-reported pain assessment and opioid consumption
Patients with ≥5 surveys completed, No. (%) 52 (96.3) 47 (97.9)
Opioid consumption
Tablets dispensed for the group, No. 550 230 <.001
Tablets dispensed per person, mean (SD) 10.1 (0.7) 4.8 (5.1)
Patients who took opioids, No. (%) 27 (51.9) 17 (36.2) .16
Tablets consumed for the group, No. (% of dispensed tablets) 135.5 (24.6) 66 (28.7)
Tablets consumed per person, mean (SD) 2.6 (3.8) 1.4 (2.5) .07
Total OMEs consumed over the week, median (IQR) 5 (0-20) 0 (0-10) .09
Total OMEs consumed over the week for those taking opioids, median (IQR) 20 (10-34) 15 (10-30) .49
OTC use, No. (%)
Acetaminophen 38 (73.1) 39 (83.0) .33
Ibuprofen 11 (21.2) 18 (38.3) .08
Naproxen 4 (7.7) 3 (6.4) >.99
Postoperative pain scores, median (IQR)
Maximum reported pain score 6 (4-8) 6 (5-7) .71
Daily peak pain score averaged across the week 3 (2-4) 3 (2-4) .85
No. of patients with alert triggered for pain score ≥8, No. (%) 17 (31.5) 11 (22.9) .27
Total number of physician-initiated telephone calls for the group triggered by survey alert, No. 28 14
No. of physician-initiated telephone calls per person, mean (SD) 0.5 (0.9) 0.3 (0.6) .13
Refill requests, No. 1 0 NA

Abbreviations: IQR, interquartile range; NA, not applicable; OME, oral morphine equivalents; POINT, postoperative opt-in narcotic treatment.